Company profile
Imagenetix, Inc.
OTC: IAGX · Healthcare · Drug Manufacturers - Specialty & Generic
#884 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ —GM —SS 37
v0.1 · 5/100 weight · pillars only
↑ listing tenure, return on assets · ↓ revenue growth (YoY), market scale
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
-70.8%
Net income (FY)
-$21.7k
Employees
5
as of 2026-08-30
Market cap
$5.7k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$824.5k$824.5k2014
Net income-$21.7k-$21.7k2014
Operating income$14.3k$14.3k2014
Total assets$8.8M$8.8M2014
Liabilities$2.5M$2.5M2014
Equity$6.3M$6.3M2014
Revenue trend
FY2004 – FY2014 · USD
FY04
FY05
FY06
FY07
FY08
FY09
FY10
FY14
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Imagenetix, Inc.’s revenue?
Imagenetix, Inc. booked $824.5k in FY2014 revenue, contracting 88% year over year — slower than 90% of Healthcare companies we track, at a -2.6% net margin.
Peers · Healthcare
Rallybio Corporation47DUniversal Ibogaine Inc.——Advantis Corp.——Catheter Precision, Inc.39DOnconetix, Inc.25DHyperion DeFi, Inc.35DNeighbors
San Diego →Key facts
CEODecky Goodrich
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSan Diego, CA
ExchangeOTC: IAGX
Employees5
IPO date2000-03-23
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.